Premium
Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions
Author(s) -
Weinmann Ann F.,
Schoof Jon M.,
Thompson Arthur R.
Publication year - 1996
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/(sici)1096-8652(199603)51:3<192::aid-ajh3>3.0.co;2-s
Subject(s) - titer , chromosomal inversion , gene , clotting factor , genetics , medicine , factor ix , biology , antibody , karyotype , chromosome
Abstract Inversions between a gene A copy within intron 22 of the factor VIII gene and additional copies outside the factor VIII gene were found in 49 families with hemophilia A. Inversion patterns were that of recombination with a distal gene A copy in 34, a proximal copy in 14, and a third (variant) copy in one. Baseline factor VIII clotting activity levels were <1% of normal in 43 and 1% in 6. No inversion was detected in 61 other families whose affected members had ≤1% activity levels nor in 42 families with moderately severe hemophilia A and 2–5% baseline levels. Both high titer and low level alloantibody inhibitors were found in patients with or without an inversion. Of 13 high titer inhibitors, 8 were persistent and 1 of these patients had an inversion. Of 5 that responded to daily factor VIII infusions, 4 were in patients with gene inversions. Of the 49 families with an inversion, the occurrence of hemophilia was isolated in 30 and the mother was a carrier in the 25 in which additional family members were informative. In three of these families with isolated occurrence, the maternal grandmother was a carrier whereas in three others a de novo mutation occurred in the maternal grandfather's factor VIII gene. Screening for gene inversions in patients with severe (or “borderline” severe) hemophilia A provides a direct marker of the mutation in 45% of families. It is useful even if there is no living affected member and in predicting the likely severity of an infant in which there are no reliable baseline clotting activities, including 70% of families with isolated occurrences of hemophilia A. © 1996 Wiley‐Liss, Inc.